An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support

ConditionSubstance Use
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLoyola Marymount University

About this trial

This randomized controlled trial (RCT) will evaluate the feasibility and efficacy of Pink Cloud, a mobile health application designed to support recovery from substance and alcohol use disorders (SUD/AUD). The app provides access to over 245,000 in-person and virtual 12-Step meetings, along with features such as a sobriety counter, daily planner, and personal inventory tools. In this study, 1,410 participants in various stages of recovery will be randomly assigned to receive either access to the Pink Cloud app or to a control condition. Participants will complete follow-up assessments at 1, 3, and 6 months. Primary outcomes include number of days sober and frequency of drug and alcohol problems. Secondary outcomes include meeting attendance, proportion of sober individuals in one's social network, and engagement in recovery-related activities. The investigators hypothesize that participants in the Pink Cloud group will report more days sober and fewer substance use problems than those in the control group, and that they will also report attending more meetings, having a greater proportion of sober peers, and engaging more frequently in recovery activities.

Eligibility criteria

Qualifiers

Participant is 18 years of age or older

Participant is willing to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week

Participant owns a personal smartphone with cellular service

Participant is a permanent resident of the United States

Disqualifiers

Participant is younger than 18 years of age

Participant is unwilling to attend a 12-Step or peer-to-peer recovery meeting (in person or virtual) within the next week

Participant does not own a personal smartphone with cellular service

Participant is not a permanent resident of the United States

Trial design

Treatments tested in this trial

  • Pink Cloud
  • Active Control

Treatment groups

1,410 Participants
are divided into 2 treatment groups

Sponsors and collaborators